P. Hoogerbrugge

Peter Hoogerbrugge, PhD
Pediatric Oncologist, Prinses Maxima Centrum, Utrecht

 

Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia

 

https://ash.confex.com/ash/2018/webprogram/Paper112599.html
 

0219KYM1113236
×

Ask Speakers

×

Medical Information Request